This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
We received an updated WNV package insert; please note the manufacturer and license number has been ...